VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1555888
Sex: M
Age: 56
State: ME

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Overall numbness of the left cheek from lower jaw and to the eye; This spontaneous case was reported by an other health care professional and describes the occurrence of HYPOAESTHESIA (Overall numbness of the left cheek from lower jaw and to the eye) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No medical history reported. On 27-Jan-2021 at 5:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021 at 5:30 AM, the patient experienced HYPOAESTHESIA (Overall numbness of the left cheek from lower jaw and to the eye). At the time of the report, HYPOAESTHESIA (Overall numbness of the left cheek from lower jaw and to the eye) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications have not been provided. Treatment information has not been provided.

Other Meds:

Current Illness:

ID: 1555889
Sex: M
Age: 76
State:

Vax Date: 02/11/2021
Onset Date: 02/12/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Aches in his joints; A headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Aches in his joints), HEADACHE (A headache) and CHILLS (Chills) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ARTHRALGIA (Aches in his joints), HEADACHE (A headache) and CHILLS (Chills). At the time of the report, ARTHRALGIA (Aches in his joints), HEADACHE (A headache) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient felt like he was experiencing COVID-19 again. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1555890
Sex: F
Age: 67
State: IN

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Couldn't sleep; Was sick all night; headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Couldn't sleep), ILLNESS (Was sick all night), HEADACHE (headache) and PYREXIA (Fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No medical history reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced INSOMNIA (Couldn't sleep), ILLNESS (Was sick all night), HEADACHE (headache) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, INSOMNIA (Couldn't sleep), ILLNESS (Was sick all night) and HEADACHE (headache) outcome was unknown and PYREXIA (Fever) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1555891
Sex: M
Age: 67
State: CA

Vax Date: 02/11/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: legs feel like lead in the morning; feel cold; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (legs feel like lead in the morning) and FEELING COLD (feel cold) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (legs feel like lead in the morning) and FEELING COLD (feel cold). At the time of the report, LIMB DISCOMFORT (legs feel like lead in the morning) and FEELING COLD (feel cold) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were reported.

Other Meds:

Current Illness:

ID: 1555892
Sex: F
Age: 79
State: ID

Vax Date: 02/07/2021
Onset Date: 02/17/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: warm to the touch.; small red mark; tchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch.), VACCINATION SITE ERYTHEMA (small red mark) and VACCINATION SITE PRURITUS (tchy) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch.), VACCINATION SITE ERYTHEMA (small red mark) and VACCINATION SITE PRURITUS (tchy). At the time of the report, VACCINATION SITE WARMTH (warm to the touch.), VACCINATION SITE ERYTHEMA (small red mark) and VACCINATION SITE PRURITUS (tchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications and treatment information were reported.

Other Meds:

Current Illness:

ID: 1555893
Sex: F
Age:
State: PA

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Rapid heart beat; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Rapid heart beat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19. On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced PALPITATIONS (Rapid heart beat). At the time of the report, PALPITATIONS (Rapid heart beat) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were reported.

Other Meds:

Current Illness:

ID: 1555894
Sex: M
Age: 77
State: AR

Vax Date: 01/26/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Arm I got the injection in is stiff; I felt weak this morning.; Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Arm I got the injection in is stiff), ASTHENIA (I felt weak this morning.) and VACCINATION SITE PAIN (Soreness at injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 042L20A) for COVID-19 vaccination. Concurrent medical conditions included Stent placement since 28-Jan-2021. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Arm I got the injection in is stiff), ASTHENIA (I felt weak this morning.) and VACCINATION SITE PAIN (Soreness at injection site). At the time of the report, MUSCULOSKELETAL STIFFNESS (Arm I got the injection in is stiff), ASTHENIA (I felt weak this morning.) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable Concomitant medications included blood thinner. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2021-024563 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15-JUL-2021 included Mailing address.

Other Meds:

Current Illness: Stent placement

ID: 1555895
Sex: F
Age: 81
State: MA

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: soreness at injection site; Swelling at Injection Site; Red Area; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), VACCINATION SITE PAIN (soreness at injection site), VACCINATION SITE SWELLING (Swelling at Injection Site) and VACCINATION SITE ERYTHEMA (Red Area) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX), PARACETAMOL (TYLENOL), PRAVASTATIN, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and GLUCOSAMINE for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), VACCINATION SITE PAIN (soreness at injection site), VACCINATION SITE SWELLING (Swelling at Injection Site) and VACCINATION SITE ERYTHEMA (Red Area). At the time of the report, HEADACHE (headache), VACCINATION SITE PAIN (soreness at injection site), VACCINATION SITE SWELLING (Swelling at Injection Site) and VACCINATION SITE ERYTHEMA (Red Area) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications include antiprosol, Adroitin, Propetigil and Arthritis Tylenol.

Other Meds: PLAVIX; TYLENOL; PRAVASTATIN; VITAMIN B12 [CYANOCOBALAMIN]; GLUCOSAMINE

Current Illness:

ID: 1555896
Sex: F
Age: 92
State: CO

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Patient reported itching on her arm, face, and neck; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Patient reported itching on her arm, face, and neck) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PRURITUS (Patient reported itching on her arm, face, and neck). At the time of the report, PRURITUS (Patient reported itching on her arm, face, and neck) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication was reported. No concomitant medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15 Jul 2021, updated event outcome to recovered and the patient declined for a follow up.

Other Meds:

Current Illness:

ID: 1555897
Sex: M
Age: 77
State:

Vax Date: 01/26/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Arm got the injection in is stiff; Felt weak; Arm got the injection in is sore; A spontaneous report was received from a consumer concerning a 77 years-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm got the injection in is sore, arm got the injection in is stiff, and felt weak. The patient's medical history was not reported. Concomitant product use included unspecified blood thinner. The patient received their first of two planned doses of mRNA-1273 (Lot number: 042L20A) on 26 Jan 2021. On 23 Feb 2021, approximately one day prior to the onset of events, the patient received their second of two planned doses of mRNA-1273 (Lot number: 022M20A) in the left arm for prophylaxis of COVID-19 infection. On 24 Feb 2021, the patient reported the arm which got the injection was sore & stiff and the patient felt weak the same morning. Patient reported forgetting to inform that patient was taking a blood thinner. Treatment information was not provided. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. The outcome of the events arm got the injection in is sore, arm got the injection in is stiff, and felt weak is unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1555898
Sex: M
Age: 70
State:

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2021-024017 (E2B Linked Report). Reporter did not allow further contact; Sender's Comments: US-MODERNATX, INC.-MOD-2021-024017:crosslink

Other Meds:

Current Illness:

ID: 1555899
Sex: F
Age: 36
State: MA

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Pregnant pt; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant pt) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 071M20A) for COVID-19 vaccination. Concurrent medical conditions included Pregnancy (During current pregnancy, she had marginal cord insertion as a pregnancy complication.). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE], COLECALCIFEROL (D3 VITAMIIN) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in July 2020 and the estimated date of delivery was 26-Apr-2021. On 20-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant pt). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. On 20-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant pt) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Aug-2020, Pregnancy test: positive positive (Positive) Pregnancy test was positive.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment details were added.

Other Meds: PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS ; D3 VITAMIIN; ASPIRIN (E.C.)

Current Illness:

ID: 1555900
Sex: F
Age:
State: PA

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Problem with close-up vision; Blurred vision; Metallic taste in her mouth; Heart started racing; Mind felt foggy; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurred vision), DYSGEUSIA (Metallic taste in her mouth), PALPITATIONS (Heart started racing), FEELING ABNORMAL (Mind felt foggy) and VISUAL IMPAIRMENT (Problem with close-up vision) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. No medical history reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VISION BLURRED (Blurred vision), DYSGEUSIA (Metallic taste in her mouth), PALPITATIONS (Heart started racing) and FEELING ABNORMAL (Mind felt foggy). On 24-Feb-2021, the patient experienced VISUAL IMPAIRMENT (Problem with close-up vision). The patient was treated with PARACETAMOL (TYLENOL) on 29-Jan-2021 for Feeling abnormal, Taste metallic and Visual impairment, at an unspecified dose and frequency. At the time of the report, VISION BLURRED (Blurred vision), DYSGEUSIA (Metallic taste in her mouth), PALPITATIONS (Heart started racing), FEELING ABNORMAL (Mind felt foggy) and VISUAL IMPAIRMENT (Problem with close-up vision) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1555901
Sex: F
Age: 49
State: PA

Vax Date: 01/25/2021
Onset Date: 02/22/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Muscle pain; Back pain; Bad body odor; Tiredness; Severe chills; Joint pain; Fever; Headache; Nausea; Vomiting; Arm burned really bad during administration; This spontaneous case was reported by an other health care professional and describes the occurrence of BURNING SENSATION (Arm burned really bad during administration), BACK PAIN (Back pain), SKIN ODOUR ABNORMAL (Bad body odor), FATIGUE (Tiredness) and CHILLS (Severe chills) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced BURNING SENSATION (Arm burned really bad during administration). On 23-Feb-2021, the patient experienced BACK PAIN (Back pain), SKIN ODOUR ABNORMAL (Bad body odor), FATIGUE (Tiredness), CHILLS (Severe chills), ARTHRALGIA (Joint pain), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea) and VOMITING (Vomiting). On 24-Feb-2021, the patient experienced MYALGIA (Muscle pain). At the time of the report, BURNING SENSATION (Arm burned really bad during administration), BACK PAIN (Back pain), SKIN ODOUR ABNORMAL (Bad body odor), FATIGUE (Tiredness), CHILLS (Severe chills), ARTHRALGIA (Joint pain), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea), VOMITING (Vomiting) and MYALGIA (Muscle pain) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. The patient took Advil (ibuprofen) and Tylenol (paracetamol).

Other Meds:

Current Illness:

ID: 1555902
Sex: F
Age: 77
State: SD

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Cough; labored breathing,Shortness of breath; Swelling of the left lymph node; Chills; Headache; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (Cough), DYSPNOEA (labored breathing,Shortness of breath), VACCINATION SITE LYMPHADENOPATHY (Swelling of the left lymph node), CHILLS (Chills) and HEADACHE (Headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced COUGH (Cough), DYSPNOEA (labored breathing,Shortness of breath), VACCINATION SITE LYMPHADENOPATHY (Swelling of the left lymph node), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue). On 15-Feb-2021, VACCINATION SITE LYMPHADENOPATHY (Swelling of the left lymph node), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) had resolved. At the time of the report, COUGH (Cough) and DYSPNOEA (labored breathing,Shortness of breath) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: No new information.

Other Meds:

Current Illness:

ID: 1555903
Sex: F
Age:
State: MA

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Flushing Rash; eyes stared to swell; fatigued; light head; rash; Turned all red; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushing Rash), EYE SWELLING (eyes stared to swell), FATIGUE (fatigued), DIZZINESS (light head) and RASH (rash) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FLUSHING (Flushing Rash), EYE SWELLING (eyes stared to swell), FATIGUE (fatigued), DIZZINESS (light head), RASH (rash) and ERYTHEMA (Turned all red). At the time of the report, FLUSHING (Flushing Rash), EYE SWELLING (eyes stared to swell), FATIGUE (fatigued), DIZZINESS (light head), RASH (rash) and ERYTHEMA (Turned all red) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant information provided. Treatment included Benadryl, Pepcid, Prednisone

Other Meds:

Current Illness:

ID: 1555904
Sex: F
Age:
State:

Vax Date:
Onset Date: 02/22/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Bed chilling; This spontaneous case was reported by a physician and describes the occurrence of CHILLS (Bed chilling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced CHILLS (Bed chilling). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Chills, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Chills, at an unspecified dose and frequency. At the time of the report, CHILLS (Bed chilling) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment medication included Motrin and Tylenol. This case was linked to MOD-2021-024573, MOD-2021-024583 (E2B Linked Report). Reporter did not allow further contact; Sender's Comments: MOD-2021-024573:Same reporter MOD-2021-024583:Same reporter

Other Meds:

Current Illness:

ID: 1555905
Sex: F
Age: 65
State: FL

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Fever; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site). On 05-Feb-2021, the patient experienced PYREXIA (Fever). At the time of the report, VACCINATION SITE PAIN (Pain at injection site) and PYREXIA (Fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant information provided. Treatment included Tylenol BID

Other Meds:

Current Illness:

ID: 1555906
Sex: F
Age: 67
State: TX

Vax Date: 01/20/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Swelling - Near Injection Site; Soreness - Near Injection Site; Fever - Temperature of 100.0F; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling - Near Injection Site), VACCINATION SITE PAIN (Soreness - Near Injection Site), PYREXIA (Fever - Temperature of 100.0F), HEADACHE (Headache) and MYALGIA (Body aches) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swelling - Near Injection Site), VACCINATION SITE PAIN (Soreness - Near Injection Site), PYREXIA (Fever - Temperature of 100.0F), HEADACHE (Headache) and MYALGIA (Body aches). At the time of the report, VACCINATION SITE SWELLING (Swelling - Near Injection Site), VACCINATION SITE PAIN (Soreness - Near Injection Site), PYREXIA (Fever - Temperature of 100.0F), HEADACHE (Headache) and MYALGIA (Body aches) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported. no treatment details reported.

Other Meds:

Current Illness:

ID: 1555907
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Off label dosing; Fatigue; Diarrhea; Hypertension; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Off label dosing), FATIGUE (Fatigue), DIARRHOEA (Diarrhea) and HYPERTENSION (Hypertension) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product LENVATINIB MESILATE (LENVIMA) for Endometrial cancer. The patient's past medical history included No adverse event. On 01-Feb-2021, the patient started LENVATINIB MESILATE (LENVIMA) (unknown route) at an unspecified dose. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced OFF LABEL USE (Off label dosing), FATIGUE (Fatigue), DIARRHOEA (Diarrhea) and HYPERTENSION (Hypertension). At the time of the report, OFF LABEL USE (Off label dosing), FATIGUE (Fatigue), DIARRHOEA (Diarrhea) and HYPERTENSION (Hypertension) had not resolved. No treatment information provided.

Other Meds: LENVIMA

Current Illness:

ID: 1555908
Sex: M
Age: 66
State: PA

Vax Date: 02/15/2021
Onset Date: 02/22/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: COVID arm; The site of injection started itching; Site of injection has red mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (The site of injection started itching) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (The site of injection started itching) and VACCINATION SITE ERYTHEMA (Site of injection has red mark). At the time of the report, VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (The site of injection started itching) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant information provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1555909
Sex: M
Age: 67
State: PA

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Heart rate of 140; Chills; Pain in arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heart rate of 140), CHILLS (Chills) and VACCINATION SITE PAIN (Pain in arm at injection site) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20n) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included APIXABAN (ELIQUIS) and LOVASTATIN for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HEART RATE INCREASED (Heart rate of 140), CHILLS (Chills) and VACCINATION SITE PAIN (Pain in arm at injection site). At the time of the report, HEART RATE INCREASED (Heart rate of 140), CHILLS (Chills) and VACCINATION SITE PAIN (Pain in arm at injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. treatment details not reported.

Other Meds: ELIQUIS; LOVASTATIN

Current Illness:

ID: 1555910
Sex: M
Age: 69
State: OH

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: felt a discomfort in his groin area; kidney was hurting on his left side; Urinating less and less amounts until I couldn't urinate for 12 hours; Dizziness; faster heart rate; Chills; problems urinating; had the feeling of going to the bathroom even though nothing came out; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HEART RATE INCREASED (faster heart rate), CHILLS (Chills), MICTURITION DISORDER (problems urinating) and DYSURIA (had the feeling of going to the bathroom even though nothing came out) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included ATENOLOL, CLOPIDOGREL BISULFATE (lisinopril), UBIDECARENONE (COQ 10) and CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced DIZZINESS (Dizziness), HEART RATE INCREASED (faster heart rate), CHILLS (Chills), MICTURITION DISORDER (problems urinating), DYSURIA (had the feeling of going to the bathroom even though nothing came out) and OLIGURIA (Urinating less and less amounts until I couldn't urinate for 12 hours). On 21-Feb-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (felt a discomfort in his groin area) and RENAL PAIN (kidney was hurting on his left side). On 21-Feb-2021, MICTURITION DISORDER (problems urinating), DYSURIA (had the feeling of going to the bathroom even though nothing came out) and OLIGURIA (Urinating less and less amounts until I couldn't urinate for 12 hours) had resolved. On 23-Feb-2021, HEART RATE INCREASED (faster heart rate) and CHILLS (Chills) had resolved. On 24-Feb-2021, MUSCULOSKELETAL DISCOMFORT (felt a discomfort in his groin area) had resolved. At the time of the report, DIZZINESS (Dizziness) and RENAL PAIN (kidney was hurting on his left side) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information provided.

Other Meds: ATENOLOL; lisinopril; COQ 10; PLAVIX

Current Illness:

ID: 1555911
Sex: M
Age: 77
State: SD

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: shortness of breath; Cough; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), COUGH (Cough) and FATIGUE (fatigue) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced DYSPNOEA (shortness of breath), COUGH (Cough) and FATIGUE (fatigue). At the time of the report, DYSPNOEA (shortness of breath) and COUGH (Cough) outcome was unknown and FATIGUE (fatigue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant information provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1555912
Sex: F
Age: 79
State: TN

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Really sick; Nauseas; Couldn't get around the house for a couple of days; Felt real sore; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Really sick), NAUSEA (Nauseas), ASTHENIA (Couldn't get around the house for a couple of days) and PAIN (Felt real sore) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concurrent medical conditions included Kidney dysfunction, Diabetes and Blood pressure high. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced ILLNESS (Really sick), NAUSEA (Nauseas), ASTHENIA (Couldn't get around the house for a couple of days) and PAIN (Felt real sore). At the time of the report, ILLNESS (Really sick), NAUSEA (Nauseas), ASTHENIA (Couldn't get around the house for a couple of days) and PAIN (Felt real sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant information provided. No treatment information provided.

Other Meds:

Current Illness: Blood pressure high; Diabetes; Kidney dysfunction

ID: 1555913
Sex: F
Age:
State: OH

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Cold; Mild UTI; Body ache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NASOPHARYNGITIS (Cold), URINARY TRACT INFECTION (Mild UTI) and PAIN (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. NO medical history information was reported. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold), URINARY TRACT INFECTION (Mild UTI) and PAIN (Body ache). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) for Urinary tract infection, at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (Cold), URINARY TRACT INFECTION (Mild UTI) and PAIN (Body ache) outcome was unknown. No relevant concomitant medications were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 25-Feb-2021. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NASOPHARYNGITIS (Cold), URINARY TRACT INFECTION (Mild UTI) and PAIN (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. NO medical history information was reported. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold), URINARY TRACT INFECTION (Mild UTI) and PAIN (Body ache). The patient was treated with SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) for Urinary tract infection, at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (Cold), URINARY TRACT INFECTION (Mild UTI) and PAIN (Body ache) outcome was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1555914
Sex: M
Age: 87
State: TN

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Seborrheic keratitis flare; Felt lousy; Sore arm; Flu like symptoms; Possible low grade fever; This spontaneous case was reported by a physician and describes the occurrence of DISCOMFORT (Felt lousy), PAIN IN EXTREMITY (Sore arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (Possible low grade fever) and SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical history information was reported. On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced DISCOMFORT (Felt lousy), PAIN IN EXTREMITY (Sore arm), INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Possible low grade fever). On an unknown date, the patient experienced SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 20-Feb-2021, DISCOMFORT (Felt lousy), INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Possible low grade fever) had resolved. On 21-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a physician and describes the occurrence of DISCOMFORT (Felt lousy), PAIN IN EXTREMITY (Sore arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (Possible low grade fever) and SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical history information was reported. On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced DISCOMFORT (Felt lousy), PAIN IN EXTREMITY (Sore arm), INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Possible low grade fever). On an unknown date, the patient experienced SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 20-Feb-2021, DISCOMFORT (Felt lousy), INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Possible low grade fever) had resolved. On 21-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, SEBORRHOEIC KERATOSIS (Seborrheic keratitis flare) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided.

Other Meds:

Current Illness:

ID: 1555915
Sex: F
Age:
State: NJ

Vax Date: 02/08/2021
Onset Date: 01/14/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Itchiness; Rash on back and sides below rib cage; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) and RASH (Rash on back and sides below rib cage) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PRURITUS (Itchiness) and RASH (Rash on back and sides below rib cage). On 26-Jan-2021, RASH (Rash on back and sides below rib cage) had resolved. On 31-Jan-2021, PRURITUS (Itchiness) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medication included anti-itch lotions (calamine) and lotion for dry skin. Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Additional information was received on 22-Apr-2021.Treatment medication included.

Other Meds:

Current Illness:

ID: 1555916
Sex: F
Age: 81
State: RI

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: lip feels different; lip swollen; didn't feel right; edge of lower lip was white; pink part of lip was inverted in a V; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ORAL DISCOMFORT (lip feels different), LIP SWELLING (lip swollen), MALAISE (didn't feel right), LIP DISCOLOURATION (edge of lower lip was white) and LIP DISORDER (pink part of lip was inverted in a V) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Glaucoma since an unknown date, Hypertension since an unknown date, Heartbeats irregular since an unknown date, Arthritis since an unknown date, Inflammation since an unknown date, Asthma since an unknown date, Vertigo since an unknown date and Headache since an unknown date. Concurrent medical conditions included Pollen allergy, Ragweed allergy, Allergy to animal (cats), Drug allergy (allergic to clindamycin) and Latex allergy. Concomitant products included MONTELUKAST SODIUM for Allergy, MELOXICAM for Arthritis, FLUTICASONE PROPIONATE (FLOVENT HFA) for Asthma, LATANOPROST (XALATAN drops 0.005%) for Glaucoma, PARACETAMOL (Tylenol Extra Strength) for Headache, ATENOLOL for Heartbeats irregular, LOSARTAN POTASSIUM for Hypertension, MESCALINE for Vertigo, FISH OIL, MULTIVITAMIN [VITAMINS NOS], IRON FERROUS SULFATE, ALPRAZOLAM and CARMELLOSE SODIUM (THERA TEARS) for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced ORAL DISCOMFORT (lip feels different), LIP SWELLING (lip swollen), MALAISE (didn't feel right), LIP DISCOLOURATION (edge of lower lip was white), LIP DISORDER (pink part of lip was inverted in a V) and DIZZINESS (dizziness). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, ORAL DISCOMFORT (lip feels different), LIP SWELLING (lip swollen), MALAISE (didn't feel right), LIP DISCOLOURATION (edge of lower lip was white), LIP DISORDER (pink part of lip was inverted in a V) and DIZZINESS (dizziness) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included Tylenol Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Outcome of events, Concomitant medications, Asthma medical history This spontaneous case was reported by a consumer and describes the occurrence of ORAL DISCOMFORT (lip feels different), LIP SWELLING (lip swollen), MALAISE (didn't feel right), LIP DISCOLOURATION (edge of lower lip was white) and LIP DISORDER (pink part of lip was inverted in a V) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Glaucoma since an unknown date, Hypertension since an unknown date, Heartbeats irregular since an unknown date, Arthritis since an unknown date, Inflammation since an unknown date, Asthma since an unknown date, Vertigo since an unknown date and Headache since an unknown date. Concurrent medical conditions included Pollen allergy, Ragweed allergy, Allergy to animal (cats), Drug allergy (allergic to clindamycin) and Latex allergy. Concomitant products included MONTELUKAST SODIUM for Allergy, MELOXICAM for Arthritis, FLUTICASONE PROPIONATE (FLOVENT HFA) for Asthma, LATANOPROST (XALATAN drops 0.005%) for Glaucoma, PARACETAMOL (Tylenol Extra Strength) for Headache, ATENOLOL for Heartbeats irregular, LOSARTAN POTASSIUM for Hypertension, MESCALINE for Vertigo, FISH OIL, MULTIVITAMIN [VITAMINS NOS], IRON FERROUS SULFATE, ALPRAZOLAM and CARMELLOSE SODIUM (THERA TEARS) for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced ORAL DISCOMFORT (lip feels different), LIP SWELLING (lip swollen), MALAISE (didn't feel right), LIP DISCOLOURATION (edge of lower lip was white), LIP DISORDER (pink part of lip was inverted in a V) and DIZZINESS (dizziness). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, ORAL DISCOMFORT (lip feels different), LIP SWELLING (lip swollen), MALAISE (didn't feel right), LIP DISCOLOURATION (edge of lower lip was white), LIP DISORDER (pink part of lip was inverted in a V) and DIZZINESS (dizziness) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included Tylenol Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Outcome of events, Concomitant medications, Asthma medical history

Other Meds: FISH OIL; MULTIVITAMIN [VITAMINS NOS]; XALATAN drops 0.005%; LOSARTAN POTASSIUM; ATENOLOL; MELOXICAM; IRON FERROUS SULFATE; MONTELUKAST SODIUM; ALPRAZOLAM; FLOVENT HFA; MESCALINE; THERA TEARS; Tylenol Extra Strength

Current Illness: Allergy to animal (cats); Arthritis; Asthma; Drug allergy (allergic to clindamycin); Glaucoma; Headache; Heartbeats irregular; Hypertension; Inflammation; Latex allergy; Pollen allergy; Ragweed allergy; Vertigo

ID: 1555917
Sex: M
Age:
State:

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: starting to experience some pain in the area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (starting to experience some pain in the area) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history information was reported. On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PAIN (starting to experience some pain in the area). At the time of the report, VACCINATION SITE PAIN (starting to experience some pain in the area) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Feb-2021 and was forwarded to Moderna on 08-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (starting to experience some pain in the area) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history information was reported. On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PAIN (starting to experience some pain in the area). At the time of the report, VACCINATION SITE PAIN (starting to experience some pain in the area) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1555918
Sex: F
Age: 76
State: IL

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: soreness; swelling; pain in neck; joint pain; muscle pain; itching; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness), VACCINATION SITE SWELLING (swelling), NECK PAIN (pain in neck), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical history information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced MYALGIA (soreness), VACCINATION SITE SWELLING (swelling), NECK PAIN (pain in neck), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and PRURITUS (itching). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, MYALGIA (soreness), VACCINATION SITE SWELLING (swelling), NECK PAIN (pain in neck), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and PRURITUS (itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness), VACCINATION SITE SWELLING (swelling), NECK PAIN (pain in neck), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical history information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced MYALGIA (soreness), VACCINATION SITE SWELLING (swelling), NECK PAIN (pain in neck), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and PRURITUS (itching). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, MYALGIA (soreness), VACCINATION SITE SWELLING (swelling), NECK PAIN (pain in neck), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and PRURITUS (itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1555919
Sex: M
Age: 69
State: PA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Fell once; wobbly legs; felt like throwing up; Tenderness on left arm; Nausea; little fever; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell once), MUSCULAR WEAKNESS (wobbly legs), MALAISE (felt like throwing up), VACCINATION SITE PAIN (Tenderness on left arm) and NAUSEA (Nausea) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004MZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced MALAISE (felt like throwing up), VACCINATION SITE PAIN (Tenderness on left arm), NAUSEA (Nausea) and PYREXIA (little fever). On 23-Feb-2021, the patient experienced FALL (Fell once) and MUSCULAR WEAKNESS (wobbly legs). On 22-Feb-2021, MALAISE (felt like throwing up), VACCINATION SITE PAIN (Tenderness on left arm), NAUSEA (Nausea) and PYREXIA (little fever) had resolved. At the time of the report, FALL (Fell once) and MUSCULAR WEAKNESS (wobbly legs) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant and treatment medications were reported. This case was linked to MOD-2021-024626 (Patient Link).

Other Meds:

Current Illness:

ID: 1555920
Sex: F
Age: 85
State: NY

Vax Date: 02/11/2021
Onset Date: 02/13/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: was breathless; Increased Heart rate; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (Increased Heart rate) and DYSPNOEA (was breathless) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced HEART RATE INCREASED (Increased Heart rate). On an unknown date, the patient experienced DYSPNOEA (was breathless). At the time of the report, HEART RATE INCREASED (Increased Heart rate) and DYSPNOEA (was breathless) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment Medications were not provided by the reporter.

Other Meds:

Current Illness:

ID: 1555921
Sex: F
Age: 74
State: FL

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: sideeffects were very painful; Pain around the injection site; joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (sideeffects were very painful), VACCINATION SITE PAIN (Pain around the injection site) and ARTHRALGIA (joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013620A and 015M20A) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Jan-2021, the patient experienced PAIN (sideeffects were very painful), VACCINATION SITE PAIN (Pain around the injection site) and ARTHRALGIA (joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN (sideeffects were very painful), VACCINATION SITE PAIN (Pain around the injection site) and ARTHRALGIA (joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff) had not resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Concomitant medications were not provided. Patient has had an MRI and CT scan procedure, results are unknown. Treatment information included prescription steroid pills discontinued. This case was linked to MOD21-069007 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Contains significant information- Patient demographics and Vaccination date for first dose has been updated, event details and treatment information was added. On 28-Apr-2021: Contains significant information- Reporter address and event details has been added. New events for second dose and treatment information added. On 28-Apr-2021: Contains significant information -A new event was added.; Sender's Comments: MOD21-069007:crosslinked

Other Meds:

Current Illness:

ID: 1555922
Sex: M
Age: 72
State: LA

Vax Date: 01/06/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: had some pain down his neck; had trouble lifting his left arm yesterday; muscle weakness; This spontaneous case was reported by a pharmacist and describes the occurrence of NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 027L20A) for COVID-19 vaccination. The patient's past medical history included Neck discomfort. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness). At the time of the report, NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a pharmacist and describes the occurrence of NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 027L20A) for COVID-19 vaccination. The patient's past medical history included Neck discomfort. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness). At the time of the report, NECK PAIN (had some pain down his neck), PAIN IN EXTREMITY (had trouble lifting his left arm yesterday) and MUSCULAR WEAKNESS (muscle weakness) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1555923
Sex: F
Age: 73
State:

Vax Date: 01/30/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Delayed type hypersensitivity; Rash; Bumped area; warm; little itchy; red; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Delayed type hypersensitivity), RASH (Rash), SWELLING (Bumped area), FEELING HOT (warm) and PRURITUS (little itchy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included SPIRONOLACTONE, AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), AMBRISENTAN, TADALAFIL and MULTIVITAMINS & MINERALS PLUS LUTEIN for an unknown indication. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed type hypersensitivity), RASH (Rash), SWELLING (Bumped area), FEELING HOT (warm), PRURITUS (little itchy) and ERYTHEMA (red). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Delayed type hypersensitivity) had not resolved and RASH (Rash), SWELLING (Bumped area), FEELING HOT (warm), PRURITUS (little itchy) and ERYTHEMA (red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: SPIRONOLACTONE; NEXIUM 1-2-3; AMBRISENTAN; TADALAFIL; MULTIVITAMINS & MINERALS PLUS LUTEIN

Current Illness:

ID: 1555924
Sex: M
Age: 64
State: VA

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: fatigue; arm was sore where I got the shot; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical history information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot). At the time of the report, FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Feb-2021 and was forwarded to Moderna on 08-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical history information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot). At the time of the report, FATIGUE (fatigue) and VACCINATION SITE PAIN (arm was sore where I got the shot) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1555925
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: a bad reaction; high fever; her whole body hurts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (a bad reaction), PYREXIA (high fever) and PAIN (her whole body hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (a bad reaction), PYREXIA (high fever) and PAIN (her whole body hurts). At the time of the report, VACCINATION SITE REACTION (a bad reaction), PYREXIA (high fever) and PAIN (her whole body hurts) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1555926
Sex: F
Age:
State: TX

Vax Date: 01/27/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Contracted covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Contracted covid-19). At the time of the report, COVID-19 (Contracted covid-19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Contracted covid-19). At the time of the report, COVID-19 (Contracted covid-19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1555927
Sex: M
Age: 69
State: PA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Wobbly legs; Fell once; Tenderness on left arm; Nausea; Little fever; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell once) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004MZ0A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced FALL (Fell once). At the time of the report, FALL (Fell once) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1555928
Sex: F
Age: 79
State: NY

Vax Date: 01/22/2021
Onset Date: 02/14/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: tingling in left shoulder to neck; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in left shoulder to neck) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (tingling in left shoulder to neck). At the time of the report, PARAESTHESIA (tingling in left shoulder to neck) was resolving. Concomitant products included unspecified medicines to treat blood pressure, cholesterol and diabetes. The patient reported the tingling she felt after second shot was coming and going at the time of follow-up information received. She reported it had been days since last felt the sensation. The patient reported that her PCP believed the tingling was more a result of a pinched nerve and possibly not related to the vaccine. No Treatment information for the event was provided. This case was linked to MOD21-14861 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Update the start date of first dose of vaccine and Event outcome for Paresthesia is recovering; Sender's Comments: MOD21-14861:First case received on 24-Jan-2021

Other Meds:

Current Illness:

ID: 1555929
Sex: F
Age: 62
State: CO

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Face was burning; Woke me up in the middle of the night; Numb left side of face / Numb Lips; Tingling left side of face / Pins and needles in the face; both hands were totally blue; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of SKIN DISCOLOURATION (both hands were totally blue), HYPOAESTHESIA (Numb left side of face / Numb Lips), PARAESTHESIA (Tingling left side of face / Pins and needles in the face), SKIN BURNING SENSATION (Face was burning) and INSOMNIA (Woke me up in the middle of the night) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No medical history information was reported. Family history included Bell's palsy (Patient's mother had Bell's Palsy twice). On 26-Jan-2021 at 4:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced SKIN DISCOLOURATION (both hands were totally blue). On 28-Jan-2021, the patient experienced HYPOAESTHESIA (Numb left side of face / Numb Lips) and PARAESTHESIA (Tingling left side of face / Pins and needles in the face). On 02-Feb-2021, the patient experienced SKIN BURNING SENSATION (Face was burning) and INSOMNIA (Woke me up in the middle of the night). On 26-Jan-2021, SKIN DISCOLOURATION (both hands were totally blue) had resolved. At the time of the report, HYPOAESTHESIA (Numb left side of face / Numb Lips), PARAESTHESIA (Tingling left side of face / Pins and needles in the face), SKIN BURNING SENSATION (Face was burning) and INSOMNIA (Woke me up in the middle of the night) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Heart rate: High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Feb-2021 and was forwarded to Moderna on 06-Feb-2021. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of SKIN DISCOLOURATION (both hands were totally blue), HYPOAESTHESIA (Numb left side of face / Numb Lips), PARAESTHESIA (Tingling left side of face / Pins and needles in the face), SKIN BURNING SENSATION (Face was burning) and INSOMNIA (Woke me up in the middle of the night) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No medical history information was reported. Family history included Bell's palsy (Patient's mother had Bell's Palsy twice). On 26-Jan-2021 at 4:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced SKIN DISCOLOURATION (both hands were totally blue). On 28-Jan-2021, the patient experienced HYPOAESTHESIA (Numb left side of face / Numb Lips) and PARAESTHESIA (Tingling left side of face / Pins and needles in the face). On 02-Feb-2021, the patient experienced SKIN BURNING SENSATION (Face was burning) and INSOMNIA (Woke me up in the middle of the night). On 26-Jan-2021, SKIN DISCOLOURATION (both hands were totally blue) had resolved. At the time of the report, HYPOAESTHESIA (Numb left side of face / Numb Lips), PARAESTHESIA (Tingling left side of face / Pins and needles in the face), SKIN BURNING SENSATION (Face was burning) and INSOMNIA (Woke me up in the middle of the night) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Heart rate: High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1555930
Sex: F
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Vaccine administered to a patient from pre-filled syringe as original vial had been punctured 16 hours prior to administration; A spontaneous report was received from a nurse concerning an unknown age old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273 ) and experienced expired product administered. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) for prophylaxis of COVID-19 infection. Patient received the vaccine from a prefilled syringe and the original vial had been punctured 16 hours prior to administration and was kept at room temperature during that period of time. Treatment information was not provided/unknown. Action taken with mRNA-1273 in response to the event was not provided. The outcome of event was resolved.; Reporter's Comments: This case concerns a female patient of unknown age who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Expired product administered without any associated adverse events.

Other Meds:

Current Illness:

ID: 1555931
Sex: F
Age: 82
State: NY

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Body itching; Tenderness at site of injection; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Body itching), INJECTION SITE PAIN (Tenderness at site of injection) and NAUSEA (Nausea) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PRURITUS (Body itching), INJECTION SITE PAIN (Tenderness at site of injection) and NAUSEA (Nausea). On 24-Feb-2021, PRURITUS (Body itching) and NAUSEA (Nausea) had resolved and INJECTION SITE PAIN (Tenderness at site of injection) outcome was unknown. Concomitant product use was not provided by the reporter. No treatment medication was provided. Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Added outcome of the events

Other Meds:

Current Illness:

ID: 1555932
Sex: F
Age: 83
State: OK

Vax Date: 01/21/2021
Onset Date: 02/04/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Left arm was inflamed; it kind of itched; area was a little swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (Left arm was inflamed), VACCINATION SITE PRURITUS (it kind of itched) and VACCINATION SITE SWELLING (area was a little swollen) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No medical history information was reported. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), LOSARTAN, ATORVASTATIN, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), CALCIUM, VITAMIN D [VITAMIN D NOS], LATANOPROST and DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE (DORZOLAMID + TIMOLOL TRB) for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE INFLAMMATION (Left arm was inflamed), VACCINATION SITE PRURITUS (it kind of itched) and VACCINATION SITE SWELLING (area was a little swollen). At the time of the report, VACCINATION SITE INFLAMMATION (Left arm was inflamed), VACCINATION SITE PRURITUS (it kind of itched) and VACCINATION SITE SWELLING (area was a little swollen) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Feb-2021 and was forwarded to Moderna on 08-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (Left arm was inflamed), VACCINATION SITE PRURITUS (it kind of itched) and VACCINATION SITE SWELLING (area was a little swollen) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No medical history information was reported. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), LOSARTAN, ATORVASTATIN, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), CALCIUM, VITAMIN D [VITAMIN D NOS], LATANOPROST and DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE (DORZOLAMID + TIMOLOL TRB) for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE INFLAMMATION (Left arm was inflamed), VACCINATION SITE PRURITUS (it kind of itched) and VACCINATION SITE SWELLING (area was a little swollen). At the time of the report, VACCINATION SITE INFLAMMATION (Left arm was inflamed), VACCINATION SITE PRURITUS (it kind of itched) and VACCINATION SITE SWELLING (area was a little swollen) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Treatment information for the event was provided.

Other Meds: BABY ASPIRIN; LOSARTAN; ATORVASTATIN; AREDS; CALCIUM; VITAMIN D [VITAMIN D NOS]; LATANOPROST; DORZOLAMID + TIMOLOL TRB

Current Illness:

ID: 1555933
Sex: F
Age: 72
State: UT

Vax Date: 01/26/2021
Onset Date: 02/02/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: soreness on right arm; itchiness; redness at injection site; rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness on right arm), PRURITUS (itchiness), ERYTHEMA (redness at injection site) and RASH (rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product CORTISONE for an unknown indication. Concurrent medical conditions included Drug allergy (Tromethamine). On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started CORTISONE (unknown route) at an unspecified dose. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness on right arm), PRURITUS (itchiness), ERYTHEMA (redness at injection site) and RASH (rash). On 02-Feb-2021, PAIN IN EXTREMITY (soreness on right arm) outcome was unknown. At the time of the report, PRURITUS (itchiness), ERYTHEMA (redness at injection site) and RASH (rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included Cortisone. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1555934
Sex: M
Age:
State: AL

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Rash on both arms; Chills; thought he had had flu or something; Shaking uncontrollably; Sore arm/couldn't lift it; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (thought he had had flu or something), TREMOR (Shaking uncontrollably), RASH (Rash on both arms), CHILLS (Chills) and PAIN IN EXTREMITY (Sore arm/couldn't lift it) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 006M20A) for COVID-19 vaccination. The patient's past medical history included Cholesterol since an unknown date and Hypertension since an unknown date. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm/couldn't lift it). On 14-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (thought he had had flu or something), TREMOR (Shaking uncontrollably) and CHILLS (Chills). On an unknown date, the patient experienced RASH (Rash on both arms). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) ongoing since an unknown date at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at an unspecified dose and frequency. On 24-Jan-2021, PAIN IN EXTREMITY (Sore arm/couldn't lift it) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (thought he had had flu or something), TREMOR (Shaking uncontrollably), RASH (Rash on both arms) and CHILLS (Chills) outcome was unknown. Concomitant medications included unspecified medications for cholesterol and blood pressure. This case was linked to MOD-2021-041706 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Feb-2021 and was forwarded to Moderna on 25-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (thought he had had flu or something), TREMOR (Shaking uncontrollably), RASH (Rash on both arms), CHILLS (Chills) and PAIN IN EXTREMITY (Sore arm/couldn't lift it) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 006M20A) for COVID-19 vaccination. The patient's past medical history included Cholesterol since an unknown date and Hypertension since an unknown date. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm/couldn't lift it). On 14-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (thought he had had flu or something), TREMOR (Shaking uncontrollably) and CHILLS (Chills). On an unknown date, the patient experienced RASH (Rash on both arms). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) ongoing since an unknown date at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at an unspecified dose and frequency. On 24-Jan-2021, PAIN IN EXTREMITY (Sore arm/couldn't lift it) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (thought he had had flu or something), TREMOR (Shaking uncontrollably), RASH (Rash on both arms) and CHILLS (Chills) outcome was unknown. Concomitant medications included unspecified medications for cholesterol and blood pressure. This case was linked to MOD-2021-041706 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the se events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Cholesterol; Hypertension

ID: 1555935
Sex: F
Age: 66
State: NC

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. No medical history information was reported. Concomitant products included ATORVASTATIN for an unknown indication. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 03-Feb-2021, PAIN IN EXTREMITY (Arm pain) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up received on 13-JUL-2021 contains non significant information.

Other Meds: ATORVASTATIN

Current Illness:

ID: 1555936
Sex: F
Age:
State: OH

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: metallic taste in her mouth; left arm is sore and tender at the injection site; little nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in her mouth), VACCINATION SITE PAIN (left arm is sore and tender at the injection site) and NAUSEA (little nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced DYSGEUSIA (metallic taste in her mouth), VACCINATION SITE PAIN (left arm is sore and tender at the injection site) and NAUSEA (little nausea). On 05-Feb-2021, VACCINATION SITE PAIN (left arm is sore and tender at the injection site) outcome was unknown. At the time of the report, DYSGEUSIA (metallic taste in her mouth) and NAUSEA (little nausea) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1555937
Sex: F
Age: 71
State: FL

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/14/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Injection site got swollen; Injection site got red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Injection site got swollen) and VACCINATION SITE ERYTHEMA (Injection site got red) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Injection site got swollen) and VACCINATION SITE ERYTHEMA (Injection site got red). At the time of the report, VACCINATION SITE SWELLING (Injection site got swollen) and VACCINATION SITE ERYTHEMA (Injection site got red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment details were not provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm